Endogenous Fungal Endophthalmitis Associated with Genitourinary Procedures

ABSTRACT Purpose: To summarize the characteristics of endogenous fungal endophthalmitis (EFE) after genitourinary procedures. Methods: Medical records of patients diagnosed with EFE after genitourinary procedures from a single center during a 6-year period were reviewed. Results: Nineteen eyes of 15 patients were included. The interval time between procedure to symptom was 3.6 ± 3.6 weeks. As the initial treatment, 9/19 eyes underwent primary vitrectomy and 10/19 eyes underwent intravitreal antifungal injection . Candida albicans was the pathogen in 15 of 19 eyes. Systemic treatment with itraconazole was used in all patients. LogMAR best corrected visual acuity improved from 2.2 ± 0.9 to 0.9 ± 1.2 after treatment (p = 0.002) in 15 eyes that were followed-up for an average of 4.9 ± 2.1 years. Conclusion: Genitourinary procedure is a predisposing factor for EFE. Candida albicans is the predominant pathogen. Normative systemic and local antifungal treatments improved the final visual outcome.

[1]  G. Piérard,et al.  Itraconazole , 2000, Reactions Weekly.

[2]  J. Duker,et al.  Endogenous Endophthalmitis Associated With Intravenous Drug Use-Reply. , 2017, JAMA ophthalmology.

[3]  M. Durand.  Bacterial and Fungal Endophthalmitis , 2017, Clinical Microbiology Reviews.

[4]  K. Bartz-Schmidt,et al.  Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis , 2017, Ocular immunology and inflammation.

[5]  A. Ellakwa,et al.  RESULTS OF PARS PLANA VITRECTOMY FOR THE MANAGEMENT OF ENDOGENOUS FUNGAL ENDOPHTHALMITIS AFTER URINARY TRACT PROCEDURES , 2017, Retinal cases & brief reports.

[6]  J. Sobel,et al.  Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  G. Gupta,et al.  THE ROLE OF EARLY VITRECTOMY IN THE TREATMENT OF FUNGAL ENDOGENOUS ENDOPHTHALMITIS. , 2016, Retinal cases & brief reports.

[9]  Darius M Moshfeghi,et al.  Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. , 2015, American journal of ophthalmology.

[10]  B. Kullberg,et al.  Invasive Candidiasis. , 2015, The New England journal of medicine.

[11]  Shriji N. Patel,et al.  ENDOGENOUS ENDOPHTHALMITIS ASSOCIATED WITH INTRAVENOUS DRUG ABUSE , 2013, Retina.

[12]  K. Mochizuki,et al.  Intraocular penetration of itraconazole in patient with fungal endophthalmitis , 2013, International Ophthalmology.

[13]  N. Narendran,et al.  A Case of Candida albicans Endophthalmitis with No Predisposing Risk Factors and a Distant Source of Infection , 2012, Case Reports in Ophthalmology.

[14]  P. McCluskey,et al.  FACTORS DETERMINING VISUAL OUTCOME IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS , 2012, Retina.

[15]  C. Lass‐Flörl.  Triazole Antifungal Agents in Invasive Fungal Infections , 2011, Drugs.

[16]  H. Flynn,et al.  Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. , 2012, American journal of ophthalmology.

[17]  Theodore Leng,et al.  Endogenous Candida albicans endophthalmitis following spontaneous abortion and IUD removal. , 2011, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[18]  J. Chhablani.  Fungal endophthalmitis , 2011, Expert review of anti-infective therapy.

[19]  Theodore Leng,et al.  Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis. , 2011, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[20]  E. O'Neill,et al.  ENDOGENOUS ENDOPHTHALMITIS ASSOCIATED WITH INTRAVENOUS DRUG ABUSE: Seven-Year Experience at a Tertiary Referral Center , 2010, Retina.

[21]  R. Ramakrishnan,et al.  Microbiological profile of culture-proven cases of exogenous and endogenous endophthalmitis: a 10-year retrospective study , 2009, Eye.

[22]  Gezhi Xu,et al.  Vitrectomy for Endogenous Fungal Endophthalmitis , 2009, Ocular immunology and inflammation.

[23]  B. Tarai,et al.  FUNGAL ENDOPHTHALMITIS: Fourteen Years’ Experience From a Center in India , 2008, Retina.

[24]  K. Pelz,et al.  Endogenous endophthalmitis: microorganisms, disposition and prognosis. , 2007, Acta ophthalmologica Scandinavica.

[25]  P. McCluskey,et al.  Endogenous Candida endophthalmitis , 2006, Expert review of anti-infective therapy.

[26]  H. Takebayashi,et al.  Relation between stage of endogenous fungal endophthalmitis and prognosis , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[27]  Yan-Qiong Zhang,et al.  TREATMENT OUTCOMES AFTER PARS PLANA VITRECTOMY FOR ENDOGENOUS ENDOPHTHALMITIS , 2005, Retina.

[28]  M. Potter.  Strategies for managing systemic fungal infection and the place of itraconazole. , 2005, The Journal of antimicrobial chemotherapy.

[29]  J. Giaconi,et al.  In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. , 2004, American journal of ophthalmology.

[30]  H. Flynn,et al.  Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. , 2004, American journal of ophthalmology.

[31]  K. Garey,et al.  Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. , 2003, Investigative ophthalmology & visual science.

[32]  P. Kaiser,et al.  Endogenous Endophthalmitis: An 18-Year Review of Culture-Positive Cases at a Tertiary Care Center , 2003, Medicine.

[33]  J. C. Nichols,et al.  Endophthalmitis in patients with disseminated fungal disease. , 2002, Transactions of the American Ophthalmological Society.

[34]  N. Vukojević,et al.  Bilateral endogenous Candida endophthalmitis after induced abortion. , 2001, Croatian medical journal.

[35]  H. Takebayashi,et al.  ANALYSIS OF PREDISPOSING CLINICAL AND LABORATORY FINDINGS FOR THE DEVELOPMENT OF ENDOGENOUS FUNGAL ENDOPHTHALMITIS: A Retrospective 12-Year Study of 79 Eyes of 46 Patients , 2001, Retina.

[36]  Carpenter,et al.  Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  J. H. Liu,et al.  Endogenous Candida endophthalmitis after induced abortion. , 1998, American journal of ophthalmology.

[38]  H. Flynn,et al.  Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. , 1997, Ophthalmic surgery and lasers.

[39]  D. D’Amico,et al.  Endogenous Fungal Endophthalmitis , 1996, International ophthalmology clinics.

[40]  C. Lowder,et al.  Endogenous endophthalmitis caused by Candida albicans in a healthy woman. , 1992, American journal of ophthalmology.

[41]  J. Edwards,et al.  OCULAR MANIFESTATIONS OF CANDIDA SEPTICEMIA: REVIEW OF SEVENTY-SIX CASES OF HEMATOGENOUS CANDIDA ENDOPHTHALMITIS , 1974, Medicine.